Records containing: Relapsing Chronic Myelogenous Leukemia
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2013-01-24A Phase I Study of Triapine in Combination With High Dose Ara-C (Hi-DAC) in Patients With Advanced Hematologic Malignancies
-
CLINICAL_TRIALS study record update · 2013-01-24A Phase I/II Trial of STI571 and High-Dose Cytarabine in Myeloid Blast Crisis of Chronic Myeloid Leukemia
-
CLINICAL_TRIALS study record update · 2013-01-23A Phase II Study Of CCI-779 In Patients With Relapsed Or Refractory Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, Or Chronic Myeloid Leukemia In Blastic-Phase
-
CLINICAL_TRIALS study record update · 2013-01-23A Phase I Study Of XL119 In Patients With Relapsed Or Refractory Acute Myeloid Leukemia, Myelodysplastic Syndromes, Acute Lymphocytic Leukemia, Or Chronic Myeloid Leukemia In Blastic-Phase
-
CLINICAL_TRIALS study record update · 2013-01-23Phase I Study of Farnesyl Transferase Inhibitor BMS-214662 (NSC 710086) in Acute Leukemias, Myelodysplastic Syndromes (RAEB and RAEB-T) and Chronic Myeloid Leukemia in Blast Phase
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2013-01-23Phase II Study of Imatinib Mesylate (Gleevec, STI-571) (NSC#716051) and Decitabine (5-AZA-2'-Deoxycitidine) (NSC#127716), in Chronic Myelogenous Leukemia in Accelerated and Blastic Phases
-
CLINICAL_TRIALS study record update · 2013-01-23Phase I Study of PS-341 in Acute Myeloid Leukemias, Myelodysplastic Syndromes and Chronic Myeloid Leukemia in Blast Phase
-
CLINICAL_TRIALS study record update · 2013-01-23Phase I and Pilot Study of Subcutaneous Homoharringtonine in Chronic Myelogenous Leukemia
-
CLINICAL_TRIALS study record update · 2013-01-16A PHASE I STUDY OF DEPSIPEPTIDE (NSC#630176, IND# 51810) IN PEDIATRIC PATIENTS WITH REFRACTORY SOLID TUMORS AND LEUKEMIAS
-
CLINICAL_TRIALS study record update · 2013-01-14A Phase I Study of CCI-779 in Combination With Imatinib Mesylate in Chronic Myelogenous Leukemia
-
CLINICAL_TRIALS study record update · 2013-01-11Phase I and Pharmacodynamic Study of SB-715992 in Acute Leukemias
-
CLINICAL_TRIALS study record update · 2013-01-09Dose Finding Study of Bryostatin-1 and GM-CSF in Refractory Myeloid Malignancies
-
CLINICAL_TRIALS study record update · 2013-01-07A Phase I Trial of SAHA (NSC 701852) and Decitabine (IND 50733, NSC 127716) in Patients With Relapsed, Refractory or Poor Prognosis Leukemia
-
CLINICAL_TRIALS study record update · 2013-01-07A Phase I/II Study of PR1 (NSC 698102) Human Leukemia Peptide Vaccine With Montanide ISA 51 (NSC 675756) or Montanide ISA 51 VG (NSC 737063) Adjuvant
-
CLINICAL_TRIALS study record update · 2012-08-14A Phase II Study of Sunitinib Malate in Idiopathic Myelofibrosis
-
CLINICAL_TRIALS study record update · 2012-07-09Pilot Study of Mechanical Stimulation for Prevention of Hematopoietic Cell Transplant Associated Bone Density Loss
-
CLINICAL_TRIALS study record update · 2012-03-07INSPIRE: An Internet-based RCT for Long-term Survivors of Hematopoietic Stem Cell Transplantation
-
CLINICAL_TRIALS study record update · 2010-08-09High-dose Busulfan, High-dose Cyclophosphamide, and Allogeneic Bone Marrow Transplantation for Leukemia, Myelodysplastic Syndromes, Multiple Myeloma and Lymphoma